X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (67) 67
index medicus (59) 59
female (47) 47
oncology (47) 47
male (44) 44
article (36) 36
cancer (36) 36
middle aged (31) 31
aged (27) 27
adult (19) 19
maximum tolerated dose (19) 19
prognosis (19) 19
head and neck cancer (18) 18
surgery (18) 18
clinical trials (17) 17
animals (16) 16
patients (15) 15
cell line, tumor (14) 14
chemotherapy (14) 14
head and neck neoplasms - pathology (14) 14
radiotherapy (14) 14
abridged index medicus (13) 13
mice (12) 12
radiation (12) 12
toxicity (12) 12
treatment outcome (12) 12
aged, 80 and over (11) 11
escalation with overdose control (11) 11
expression (11) 11
metastasis (11) 11
survival (11) 11
immunohistochemistry (10) 10
neoplasm staging (10) 10
retrospective studies (10) 10
survival rate (10) 10
therapy (10) 10
carcinoma, squamous cell - pathology (9) 9
cardiovascular (9) 9
dose-response relationship, drug (9) 9
neck (9) 9
physics (9) 9
squamous cell carcinoma (9) 9
adolescent (8) 8
analysis (8) 8
beer (8) 8
biochemistry (8) 8
cancer phase i trials (8) 8
care and treatment (8) 8
chemistry (8) 8
compositions or test papers therefor (8) 8
compositions thereof (8) 8
condition-responsive control in microbiological orenzymological processes (8) 8
culture media (8) 8
design (8) 8
drugs (8) 8
enzymology (8) 8
head (8) 8
head and neck neoplasms - metabolism (8) 8
investigating or analysing materials by determining theirchemical or physical properties (8) 8
measuring (8) 8
measuring or testing processes involving enzymes, nucleicacids or microorganisms (8) 8
medical research (8) 8
metallurgy (8) 8
microbiology (8) 8
microorganisms or enzymes (8) 8
mutation or genetic engineering (8) 8
neoplasms - drug therapy (8) 8
processes of preparing such compositions (8) 8
propagating, preserving or maintaining microorganisms (8) 8
research (8) 8
risk factors (8) 8
spirits (8) 8
statistics & probability (8) 8
survival analysis (8) 8
testing (8) 8
time factors (8) 8
vinegar (8) 8
wine (8) 8
antineoplastic agents - administration & dosage (7) 7
antineoplastic agents - therapeutic use (7) 7
apoptosis - drug effects (7) 7
cancer therapies (7) 7
computer simulation (7) 7
continual reassessment method (7) 7
designs (7) 7
drug combination (7) 7
drug dosages (7) 7
ewoc (7) 7
hematology, oncology and palliative medicine (7) 7
lymphatic metastasis (7) 7
outcomes (7) 7
overdose (7) 7
overdose control (7) 7
paclitaxel (7) 7
radiology, nuclear medicine & medical imaging (7) 7
squamous-cell carcinoma (7) 7
usage (7) 7
young adult (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
bayesian analysis (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the Royal Statistical Society: Series C (Applied Statistics), ISSN 0035-9254, 01/2019, Volume 68, Issue 1, pp. 235 - 250
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2019, Volume 14, Issue 1, p. e0210139
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2007, Volume 25, Issue 31, pp. 4982 - 4986
Purpose Phase I clinical trials of new anticancer therapies determine suitable doses for further testing. Optimization of their design is vital in that they... 
CONTINUAL REASSESSMENT METHOD | DOSE-ESCALATION | OVERDOSE CONTROL | ONCOLOGY | CANCER | CLINICAL-TRIALS | Clinical Trials, Phase I as Topic - standards | Humans | Diffusion of Innovation | Research Design - standards | Antineoplastic Agents - therapeutic use | Therapies, Investigational - standards | Neoplasms - drug therapy
Journal Article
Statistics in Medicine, ISSN 0277-6715, 01/2017, Volume 36, Issue 2, pp. 280 - 290
Journal Article
Cancer, ISSN 0008-543X, 10/2017, Volume 123, Issue 20, pp. 3933 - 3942
Journal Article
Statistics in Medicine, ISSN 0277-6715, 09/2014, Volume 33, Issue 22, pp. 3815 - 3815
We present a Bayesian adaptive design for dose finding of a combination of two drugs in cancer phase I clinical trials. The goal is to estimate the maximum... 
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 08/2018, Volume 124, Issue 15, pp. 3154 - 3162
Journal Article
Journal of probability and statistics, ISSN 1687-952X, 2018, Volume 2018, pp. 1 - 11
A Bayesian adaptive design for dose finding of a combination of two drugs in cancer phase I clinical trials that takes into account patients heterogeneity... 
Biometrics | Medical research | Parameter estimation | Toxicity | Clinical trials | Patients | Cancer therapies | Medicine | Design | Chemotherapy | Current distribution | Bayesian analysis | Drug dosages | Cancer | Drug combination | Discrete dose | Dose limiting toxicity | Maximum tolerated dose | Baseline covariate | Escalation with overdose control | Cancer Phase I trials | Continuous dose
Journal Article
Journal Article
Journal Article